![]() |
市场调查报告书
商品编码
1980223
尿液流量计市场规模、份额、成长及全球产业分析:按类型、应用和地区分類的洞察,2026-2034 年预测Urinary Flow Meters Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球尿流量计市场规模为2,320万美元,预计2026年将成长至2,510万美元。到2034年,该市场预计将达到5,010万美元,2026年至2034年的复合年增长率为9%。 2025年,北美在全球市场中占据领先地位,占总营收的39.5%。
尿流率仪(也称为尿流计)是一种用于测量尿液流速和尿量的诊断设备。这些系统有助于诊断泌尿系统疾病,例如良性前列腺增生(BPH)、尿失禁、闭尿症、膀胱癌和摄护腺癌。由于其操作简便、性能优异、测量精准,且能与数位系统集成,因此在医院和专科诊所中的应用显着增加。
市场动态
市场驱动因素
泌尿系统疾病盛行率增加
全球泌尿系统疾病负担日益加重是推动市场成长的主要因素。应力性尿失禁的盛行率很高,这显着提高了尿流率检测的需求。
老年人口增加
随着全球老年人口的增长,泌尿系统功能障碍的风险也增加。与老龄化相关的膀胱问题和良性前列腺增生显着推高了对诊断设备的需求。欧洲超过五分之一的人口年龄在65岁以上,受这些人口结构变化的影响,该地区正经历强劲的成长。
技术进步和新产品的发布
製造商正陆续推出可与电子健康记录(EMR)系统整合的先进PC型尿流率仪,这些尿流率仪不仅提高了测量精度,还支援数位化诊断。这些创新正在加速其在技术先进的医疗机构中的应用。
新冠疫情的影响
新冠肺炎疫情导致患者就诊量下降,医院资源也因应对疫情而重新分配,对市场收入造成了负面影响。泌尿系统领域,病床运转率和门诊病人就诊量均下降。然而,随着2021年和2022年手术和诊断就诊的恢復,市场逐渐恢復到疫情前的成长水平,预计2025年后将持续稳定成长。
市场趋势
从非PC型设备迁移到PC型设备
市场的一个主要趋势是转向基于PC的尿流量计。这些系统具有以下优势:
随着医疗保健系统数位化,预计在整个预测期内,对基于个人电脑的设备的需求将保持强劲。
市场限制因素
儘管预计市场将保持强劲成长,但以下因素可能会阻碍市场扩张:
这些因素导致价格敏感地区的采用率较低。
按类型
从市场区隔来看,尿流量计分为 PC 为基础的类别和非 PC 为基础的类别。
最终用户
市场分为医院、专科诊所和其他机构。
北美洲
预计到2025年,北美市场规模将达到920万美元,以39.5%的市占率持续保持领先地位。这一增长主要得益于基于个人电脑设备的普及率高、医疗保健基础设施完善以及前列腺癌和膀胱癌发病率的上升。该地区持续推出新产品,并致力于推动数位化诊断。
欧洲
欧洲占据了相当大的市场份额,预计到2034年将保持稳定成长。人口老化加剧和膀胱癌高发生率是推动该地区市场扩张的主要因素。现有的大型企业和完善的医疗保健体系进一步巩固了市场地位。
亚太地区
预计亚太地区在预测期内将录得最高的复合年增长率。人口快速老化、人们对泌尿器官系统健康的日益关注以及日本、中国和印度等国不断扩大的医疗保健投资,正在推动该地区的需求成长。
世界其他地区
由于医疗基础设施的改善和泌尿系统疾病诊断率的提高,拉丁美洲、中东和非洲的市场正在成长。
The global urinary flow meters market was valued at USD 23.2 million in 2025 and is projected to grow to USD 25.1 million in 2026. The market is expected to reach USD 50.1 million by 2034, registering a CAGR of 9% during 2026-2034. North America dominated the global market in 2025, accounting for 39.5% of total revenue.
Urinary flow meters, also known as uroflowmeters, are diagnostic devices used to measure the rate and volume of urine flow. These systems assist in diagnosing urinary tract disorders such as benign prostatic hyperplasia (BPH), urinary incontinence, urine retention, bladder cancer, and prostate cancer. Their ease of use, improved handling, accurate measurement capabilities, and integration with digital systems have significantly increased adoption across hospitals and specialty clinics.
Market Dynamics
Market Drivers
Rising Prevalence of Urological Disorders
The increasing global burden of urinary tract disorders is a major factor driving market growth. Conditions such as BPH, stress urinary incontinence (SUI), bladder obstruction, and prostate cancer are becoming more common, particularly among aging populations. For instance, studies indicate high prevalence of SUI among women in countries such as China, significantly boosting demand for uroflowmetry testing.
Growing Geriatric Population
The global elderly population continues to rise, increasing susceptibility to urinary dysfunction. Age-related bladder issues and prostate enlargement significantly contribute to demand for diagnostic devices. Europe, where more than one-fifth of the population is aged 65 and above, represents a strong growth region due to this demographic shift.
Technological Advancements and Product Launches
Manufacturers are increasingly launching advanced PC-based urinary flow meters that integrate with Electronic Medical Records (EMRs), offer enhanced accuracy, and support digital diagnostics. These innovations are strengthening adoption across technologically advanced healthcare settings.
COVID-19 Impact
The COVID-19 pandemic negatively affected market revenues due to reduced patient visits and reallocation of hospital resources toward pandemic care. Urology departments experienced reduced bed occupancy and outpatient visits. However, with the resumption of surgical procedures and diagnostic visits in 2021 and 2022, the market gradually returned to pre-pandemic growth levels, supporting steady expansion from 2025 onward.
Market Trends
Transition from Non-PC Based to PC-Based Devices
A key market trend is the increasing shift toward PC-based urinary flow meters. These systems provide:
As healthcare systems continue digitization, demand for PC-based devices is expected to remain strong throughout the forecast period.
Market Restraints
Despite strong growth prospects, certain factors may hinder expansion:
These factors reduce adoption rates in price-sensitive regions.
By Type
The market is segmented into PC-Based and Non-PC Based urinary flow meters.
By End-User
The market is categorized into hospitals, specialty clinics, and others.
North America
North America generated USD 9.2 million in 2025, maintaining its leadership with a 39.5% market share. Growth is driven by high adoption of PC-based devices, strong healthcare infrastructure, and rising prevalence of prostate and bladder cancers. The region continues to see new product launches and digital diagnostic initiatives.
Europe
Europe held a substantial market share and is projected to grow steadily through 2034. Rising geriatric population and high prevalence of bladder cancer support regional expansion. Established players and well-developed healthcare systems further strengthen the market.
Asia Pacific
Asia Pacific is expected to register the highest CAGR during the forecast period. Rapid aging populations, increasing awareness of urinary health, and growing healthcare investments in countries such as Japan, China, and India are driving regional demand.
Rest of the World
Markets in Latin America, the Middle East, and Africa are growing due to improving healthcare infrastructure and rising diagnosis rates of urological conditions.
Competitive Landscape
Key players operating in the global urinary flow meters market include:
Companies are focusing on mergers, acquisitions, regulatory approvals, and product innovations to strengthen their global footprint.
Conclusion
The global urinary flow meters market demonstrates strong growth potential, increasing from USD 23.2 million in 2025 to USD 25.1 million in 2026, and projected to reach USD 50.1 million by 2034, at a 9% CAGR. Rising prevalence of urological disorders, expanding geriatric population, technological advancements, and growing digital integration in healthcare are key growth drivers. While high costs and limited awareness in developing regions may pose challenges, increasing innovation and expanding diagnostic infrastructure are expected to sustain long-term market expansion worldwide.
Segmentation By Type
By End-user
By Geography